RGS20 reduces glioma stemness and temozolomide resistance by intrinsically inhibiting the WNT/β-catenin signaling pathway.
Xie Y, Li Q, Ma Y, Yang Y, Jin X, Yi T, Ge X, Xu X, Yang X, Huang Q, Lu Y, Li P, Li W, Wang X, Piao Y, Jin X.
Xie Y, et al. Among authors: li w, li q, li p.
Sci Rep. 2025 Nov 28. doi: 10.1038/s41598-025-30291-z. Online ahead of print.
Sci Rep. 2025.
PMID: 41315804
Free article.